Riedhammer Thomas M 4
4 · Ohr Pharmaceutical Inc · Filed Oct 18, 2017
Insider Transaction Report
Form 4
Riedhammer Thomas M
Director
Transactions
- Award
Stock Option (right to buy)
2017-10-16+170,000→ 170,000 totalExercise: $0.67Exp: 2022-10-15→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]1/3 of the shares of common stock subject to the stock option became exercisable immediately, and 1/3 of the shares of common stock subject to the stock option will become exercisable on each of October 16, 2018 and October 16, 2019.